Division of Science Policy

The Division of Science and Public Health Policy is the ASPE lead on public health and biomedical science issues and initiatives, including programmatic and policy areas that involve complex or rapidly evolving science and technology. The Division provides technical assistance on regulatory impact analysis development to HHS agencies and offices. The Division is responsible for policy coordination; long-range planning; legislative development; economic, program, and regulatory analysis; and evaluation focused on the HHS science and public health agencies – the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), and Office of the Assistant Secretary for Preparedness and Response (ASPR). Examples of issue areas include:

  • Biomedical innovation
  • Biomedical research policy
  • Medical product regulation
  • Drug development, safety, availability, and pricing
  • Public health and emergency preparedness, response, and recovery
  • Opioid epidemic response
  • Emerging infectious diseases
  • Prevention of chronic diseases
  • Food safety